SBIR/STTR Research Award

Gene Expression in Engineered Human Skin

Award identifier 943132d63fb8633100f95c454d6d6f5d0907d5639dda16a660bf2507e6187207Awarding agency Department of Health and Human Services · National Institutes of Health

Award amount

$125,735

Program and phase

STTR · Phase I

Award year

2001

Explore This Research Award in CaptureIQ

Research the technology, evaluate the recipient and agency, identify related opportunities, and explore potential follow-on work with CaptureIQ.

Award details

Awarding agency
Department of Health and Human Services
Branch
National Institutes of Health
Recipient company
Dermigen, Inc.
Proposal award date
Not reported
Contract end date
Not reported
UEI
Not reported
Solicitation number
Not reported
Topic code
Not reported

Research abstract

DESCRIPTION (provided by applicant): Exposure of humans to sunlight produces adaptive and pathological responses in the skin, including erythema (inflammation), tanning, photoaging, photoallergy and carcinogenesis. These responses involve the modulation of gene expression and excessive exposure can result in mutation and tumorigenesis. The effects produced by ultraviolet radiation (UVR) can be modulated by a number of chemicals applied topically or systemically. The proposed research will explore the use of engineered human skin (EHS), an in vitro model possessing a dermis and differentiated epidermis, to evaluate chemical agents that modulate UVR-induced responses in skin. Initial studies (Phase I) will focus on proof-of-concept using EHS and gene expression technology to identify a set of genes that undergo modulation in response to exposure to simulated sunlight. Follow-on research (Phase II) will validate the model using a defined set of known chemical modulators of UVR-induced skin damage and will extend these studies to the use of EHS incorporating adnexal specialized cell types, e.g. melanocytes and Langerhans cells. Gene expression will be monitored after single and multiple exposures to UVR. Identification of gene expression biomarkers will allow the development of reagents or processes to screen for protective or deleterious effects of chemical agents on UVR-exposed EHS, potentially reducing the need for assays using experimental animals or human subjects. PROPOSED COMMERCIAL APPLICATION: The proposed research utilizes engineered human skin (an in vitro model possessing a dermis and differentiated epidermis) and gene expression technology to identify a set of genes that undergoes modulation in response to exposure to ultraviolet radiation (UVR). Identification of such biomarkers will allow the development of reagents or processes to screen for protective or deleterious effects of chemical agents on UVR exposed human skin, potentially reducing the need for assays using experimental animals or human subjects.

Technology keywords

Not reported

Agency intelligence

Department of Health and Human Services

Back to SBIR/STTR Research Awards

Don't take our word for it. Ask AI about RFPCapture.

See what leading AI assistants have to say about RFPCapture and CaptureIQ.

Gemini opens without a prefilled question. The question is copied to your clipboard when the button works. You can also copy it here:

What is RFPCapture.com and its CaptureIQ platform from Smart Logic AI? How does it help federal contractors discover opportunities, evaluate bid/no-bid decisions, research government contracts, and prepare proposals? How does it compare with other federal capture platforms? Use independent sources where available.